NEW YORK, July 23, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces that a class action lawsuit has been filed against Oddity Tech (“Oddity Tech” or the “Company”) (NASDAQ: ODD) in the United States District Court for the Eastern District of New York on behalf of all persons and entities who purchased or otherwise acquired Oddity Tech securities between July 19, 2023 and May 20, 2024, both dates inclusive (the “Class Period”). Investors hav ...

Investors looking for stocks in the Medical - Biomedical and Genetics sector might want to consider either Genmab A/S Sponsored ADR (GMAB) or Techne (TECH) . But which of these two stocks presents investors with the better value opportunity right now? Let's take a closer look.There are plenty of strategies for discovering value stocks, but we have found that pairing a strong Zacks Rank with an impressive grade in the Value category of our Style Scores system produces the best returns. The proven Zacks Rank ...

Investors with an interest in Medical - Biomedical and Genetics stocks have likely encountered both Genmab A/S Sponsored ADR (GMAB) and Techne (TECH) . But which of these two stocks presents investors with the better value opportunity right now? Let's take a closer look.There are plenty of strategies for discovering value stocks, but we have found that pairing a strong Zacks Rank with an impressive grade in the Value category of our Style Scores system produces the best returns. The proven Zacks Rank emphas ...

SCOTTSDALE, Ariz., June 12, 2024 /PRNewswire/ -- (OTC Pink: CETI), Cyber Enviro-Tech, Inc. an international eco-conscious remediation company, is pleased to announce the signing of a Memorandum of Understanding to acquire a Salt Water Disposal (SWD) facility in the Permian Basin of West Texas. CETI will collaborate with a long-established SWD and oil field operating company to restore this facility to full operational condition. The goal is to develop a Pilot SWD facility that not only manages water disposa ...

SCOTTSDALE, Ariz., June 6, 2024 /PRNewswire/ -- (OTCQB: CETI), CETI has unveiled its technological breakthrough for removing insecticides, nitrates, phosphates, and cyanide from heavily contaminated agricultural, industrial and mining wastewater. This has significant implications for potable water since, around the world, agriculture alone accounts for approximately 70% of the water that is consumed annually. The runoff from those farms can directly impact available potable water as these chemicals are noto ...

MINNEAPOLIS, May 31, 2024 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that Kim Kelderman, President and Chief Executive Officer will present at the following investor conferences: William Blair 44th Annual Growth Conference June 4, 2024 9:20 AM CDT Jefferies Global Healthcare Conference June 6, 2024 9:30 AM EDT Goldman Sachs 45th Annual Global Healthcare Conference June 11, 2024 9:20 AM EDT A live webcast of the presentations can be accessed via the IR Calendar page of Bio-Techne's ...

MINNEAPOLIS, May 23, 2024 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that Kim Kelderman, President and Chief Executive Officer will present at the 2024 Leerink Partners Healthcare Crossroads Conference on Wednesday, May 29, 2024, at 8:40 a.m. CDT. A live webcast of the presentation can be accessed via the IR Calendar page of Bio-Techne's Investor Relations website at https://investors.bio-techne.com/ir-calendar. About Bio-Techne Bio-Techne Corporation (NASDAQ: TECH) is a global li ...

MINNEAPOLIS, May 22, 2024 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) and Regulus Therapeutics Inc., a biopharmaceutical company focused on the discovery and development of innovative medicines targeting microRNAs, today announced continued technical and clinical collaboration following release of Regulus' positive topline results from the second cohort of patients in its Phase 1b MAD (multiple ascending dose) study of RGLS8429 for the treatment of Autosomal Dominant Polycystic Kidney Disease (ADP ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024, or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 0-17272 BIO-TECHNE CORPORATION (Exact name of registrant as specified in its charter) Minnesota 41-1427402 (State or other jur ...

Bio-Techne Corporation (NASDAQ:TECH) Q3 2024 Earnings Conference Call May 1, 2024 9:00 AM ET Company Participants David Clair – Vice President-Investor Relations Kim Kelderman – President and Chief Executive Officer Jim Hippel – Chief Financial Officer Conference Call Participants Puneet Souda – Leerink Partners Patrick Donnelly – Citi Justin Bowers – Deutsche Bank Dan Arias – Stifel Matt Larew – William Blair Catherine Schulte – Baird Sung Ji Nam – Scotia Bank Paul Knight – KeyBanc Capital Markets Operator ...